University of Gothenburg
Alzheimer's Drug Discovery Foundation Awards $5.5M in Grants for Diagnostic Development
The grants were awarded through the organization's Diagnostic Accelerator, a partnership between the charity and various philanthropic partners.
The researchers said that their approach using 11 plasma protein biomarkers could enable early detection of ovarian cancers and reduce unneeded, associated surgeries.
Neurofilament light protein may be able to determine when an athlete who's suffered a concussion can safely return to playing again, researchers said.